Aurobindo Pharma's CuraTeQ secures UK's MHRA approval for Dyrupeg
By Aman Shukla Published on June 24, 2025, 16:58 IST
CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Ltd, has received marketing authorization from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg™ , a biosimilar of pegylated filgrastim. This marks the company's third biosimilar approval in the UK, following Bevqolva™ in December 2024 and Zefylti™ in May 2025.
The latest approval adds to Dyrupeg's regulatory success, as it had already secured a marketing nod from the European Commission (EC) in April 2025. Pegylated filgrastim is commonly used to reduce infection risk in cancer patients undergoing chemotherapy, and the launch of Dyrupeg™ is expected to enhance patient access to affordable biologic therapies across Europe and the UK.
In the exchange filing, the compamy shared, 'CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Ltd, has obtained marketing authorization from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg™, its pegylated filgrastim biosimilar version. Earlier in April 2025, Dyrupeg™ received marketing authorization in the European Union from the European Commission (EC). This is CuraTeQ's third biosimilar to be approved by MHRA after the approval of Bevqolva™ in December 2024 and Zefylti™ in May 2025.'
With this milestone, CuraTeQ continues to strengthen its biosimilar portfolio and expand its footprint in the global biopharmaceutical market.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
12 minutes ago
- Business Upturn
Tata Technologies and Amazon Web Services launch 3rd edition of InnoVent Hackathon for engineering students
Tata Technologies has launched the third edition of its national engineering hackathon, InnoVent 2026 , in collaboration with Amazon Web Services (AWS). The program is open to third- and fourth-year engineering students across India and focuses on real-world mobility challenges. This year's theme, 'Innovating the Future of Smart Mobility,' invites students to build solutions using technologies such as Artificial Intelligence (AI), Generative AI, Agentic AI, IoT, Embedded Software, Cloud Computing, Digital Twins, and AR/VR. Project areas include software-defined vehicles, intelligent manufacturing, connected communications, autonomous systems, and immersive mobility experiences. The hackathon follows a three-stage evaluation process: initial screening, virtual Proof of Concept (PoC) presentations, and final demos. Tata Technologies' subject matter experts will mentor the top teams, while AWS will provide selected participants with access to its cloud technologies and conduct hands-on workshops. Project evaluation criteria include technical diversity, innovation, feasibility, and impact—with an emphasis on agentic systems, physical prototypes, and inclusive team participation. The competition also encourages participation from women and differently abled engineering students. Top teams will be eligible for cash prizes totaling ₹4.5 lakhs, paid internship opportunities at Tata Technologies, and special recognition awards. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
12 minutes ago
- Business Upturn
L&T Technology Services secures $50 million deal in sustainability segment from global energy major
L&T Technology Services Limited (BSE: 540115, NSE: LTTS) has signed a five-year agreement worth over USD 50 million with a major global energy company. The deal positions LTTS as the exclusive global engineering partner for Enterprise Data and Digital Services within the client's sustainability operations. The agreement expands on a working relationship that has existed between the two companies for more than a decade. Under this new framework, LTTS will provide enterprise data and digital services to the client's affiliates worldwide. LTTS, with more than 20 years of experience in engineering, manufacturing services, digital transformation, and enterprise data management, will support the client's digital initiatives using its global delivery model. The company is expected to manage and execute high-performance and quality-focused digital services through the duration of the agreement. Amit Chadha, CEO and Managing Director of L&T Technology Services, said, 'This large deal win in our Sustainability segment with a leading energy major has been possible due to LTTS' unique credentials which include enabling over 600 major plants across the globe. By combining our proven track record in plant engineering with state-of-the-art new age technologies, we will support the client in their digital transformation while enhancing overall operational excellence. Together, we are building a resilient, technology-driven roadmap for the energy industry' This development further strengthens LTTS's position in the energy and sustainability space, where digital transformation and data-driven solutions continue to be a strategic focus. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
12 minutes ago
- Business Upturn
MCX shares jump 3% as UBS maintains ‘Buy'rating, raises target to Rs 10,000
MCX shares jumped 3% in morning trade after global brokerage UBS reaffirmed its bullish view on the company, maintaining a 'Buy' rating and raising the target price to ₹10,000 per share from ₹7,000 earlier. As of 9:28 AM, the shares were trading 3.07% higher at Rs 8,468.00. The sharp revision in price target reflects growing confidence in MCX's business outlook, supported by strong market trends and upcoming product launches. UBS highlighted that the volatility in key commodity prices is likely to support higher trading volumes on the exchange. According to the brokerage, this volatility, combined with visible momentum in new product introductions, could drive robust growth in the near term. UBS also noted that MCX has been showing encouraging signs in terms of product rollout speed and clarity, which further strengthens its investment case. The recent performance also supports this view. In the first quarter, average daily volumes on the exchange remained healthy, with futures trading volumes rising 50% on a quarter-on-quarter basis. Meanwhile, the options premium recorded a 30% increase. This strong operational momentum signals that MCX is well-positioned to benefit from current market conditions. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
